FDA Drug information
TIAZAC EXTENDED RELEASE
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- TIAZAC EXTENDED RELEASE DILTIAZEM HYDROCHLORIDE 120 mg/1 Bausch Health US, LLC
- TIAZAC EXTENDED RELEASE DILTIAZEM HYDROCHLORIDE 180 mg/1 Bausch Health US, LLC
- TIAZAC EXTENDED RELEASE DILTIAZEM HYDROCHLORIDE 240 mg/1 Bausch Health US, LLC
- TIAZAC EXTENDED RELEASE DILTIAZEM HYDROCHLORIDE 300 mg/1 Bausch Health US, LLC
- TIAZAC EXTENDED RELEASE DILTIAZEM HYDROCHLORIDE 360 mg/1 Bausch Health US, LLC
- TIAZAC EXTENDED RELEASE DILTIAZEM HYDROCHLORIDE 420 mg/1 Bausch Health US, LLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.